It is well-known in medicine that a heart attack (myocardial infarction) is not just a single, acute clinical episode. It is often followed by severe and long-term complications, the most dangerous of which is the development of heart failure. During a heart attack, the heart muscle suffers complex and multifaceted damage, initiating inflammatory processes, scar tissue formation, heart cell death, and a sharp decline in blood circulation. Consequently, traditional treatment methods focused on only one specific issue often fail to achieve the desired results. However, Japanese scientists from Osaka University have made a revolutionary breakthrough in this field, as reported in a new study published in the scientific journal “Small Science.”
The Japanese researchers decided to confront heart damage using a comprehensive, multifaceted approach. They developed a unique therapy that involves the simultaneous delivery of five different therapeutic messenger RNAs (mRNAs). These molecules program the body to produce five specific proteins critically essential for heart tissue regeneration and recovery. To deliver these molecules safely and target them directly to the damaged areas, the scientists used special polymer-based carriers called polyplex nanomicelles.
According to Keiji Itaka, the lead author of the study, the experimental results turned out to be far more positive than anticipated. Laboratory tests conducted on mouse models demonstrated that the combined synergy of the five mRNA molecules significantly reduced the death rate of heart muscle cells, blocked the development of tough scar tissue, and promoted the formation of new blood vessels (angiogenesis). The combination of these processes dramatically accelerated the natural self-repair of the damaged areas.
Therapy with this medicinal cocktail was directly reflected in the survival rate of the animals and their cardiac function. As a result of the treatment, the contractility of the heart muscle significantly improved, the optimal thickness of the heart walls was restored, and blood flow within the cardiovascular system stabilized. The scientists emphasize that initiating treatment in the early stages following a heart attack and utilizing this combined therapy effectively ensures that cardiac function is not severely compromised in the long term.
This innovative discovery practically proves that combating heart failure is far more effective when its multifaceted nature is taken into account. The results achieved by the Osaka University scientists lay the foundation for a completely new generation of heart disease treatments and establish mRNA-based approaches as a primary, solid pillar in regenerative medicine. The authors of the project hope that following the successful preclinical stage, this technology will soon transition to the clinical trial phase in humans, offering millions of patients a chance for full and rapid rehabilitation after a heart attack.
